IOVANCE BIOTHERAPEUTICS, INC. Quarterly Amortization of Intangible Assets in USD from Q2 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Iovance Biotherapeutics, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q2 2022 to Q3 2024.
  • Iovance Biotherapeutics, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $5.5M, a 37.5% increase year-over-year.
  • Iovance Biotherapeutics, Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $19.6M.
  • Iovance Biotherapeutics, Inc. annual Amortization of Intangible Assets for 2023 was $9.85M.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $19.6M $5.5M +$1.5M +37.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $18.1M $5.5M +$3.6M +189% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $14.5M $4.63M +$4.63M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $9.85M $3.95M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $4M +$4M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $1.9M +$1.9M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.